Home | Next in Neuro

Next in Neuro provides medical education that advances the field of neuroscience

Shape your personalized learning experience

I am interested in

I want to explore the Schizophrenia topic:

Featured Content

Image

Schizophrenia

A Balancing Act: Interacting Neurotransmitter Pathways in Schizophrenia

This foundational article examines schizophrenia as a multi-pathway disorder involving interacting dopamine, serotonin, glutamate, GABA, and acetylcholine systems, highlighting how distributed neurotransmitter dysfunction may contribute to positive, negative, and cognitive symptom domains. The article explores how these pathways intersect across neural circuits and supports a broader, disease-focused understanding of schizophrenia neurobiology beyond any single neurotransmitter.

Read
Image

Schizophrenia

Understanding Antipsychotic Polypharmacy in Real-World Practice

This educational infographic for US health care professionals summarizes real-world data on antipsychotic polypharmacy in schizophrenia across four domains: prevalence and clinical correlates, medication adherence, adverse events, and resource utilization, highlighting the potential risks and costs associated with combination antipsychotic therapy.

Read
Image

Schizophrenia

Strategies for Rational Prescribing in Schizophrenia

This educational piece examines the rationale and real-world drivers of polypharmacy in schizophrenia, including clinical complexity and system-level factors. It highlights the trade-offs between symptom control and cumulative treatment burden, emphasizing the risks associated with increased regimen complexity and the need for ongoing reassessment. The content underscores the importance of coordinated, individualized care to support rational prescribing decisions in routine practice.

Read
Image

Schizophrenia

Polypharmacy in Schizophrenia: Understanding Its Drivers and Potential Impact

This beginner-level educational article provides an overview of the prevalence, clinical drivers, system-level contributors, and potential impact of polypharmacy in schizophrenia management. It examines why polypharmacy persists in real-world practice despite limited evidence of efficacy, highlighting the role of illness severity, treatment response, and fragmented care transitions. The article concludes by emphasizing the need for guideline-concordant treatment, careful reassessment of ongoing medication needs, and a nuanced understanding of the chronic, unremitting nature of schizophrenia in informing treatment decisions.

Read

Explore by Disease State

Schizophrenia

A complex neuropsychiatric condition involving disturbances in perception, cognition, and functioning. Explore evidence-based insights that reflect the evolving scientific understanding of symptom domains and overall disease burden.